• 1. Acentric and chiral heterometallic inorganic–organic hybrid frameworks mediated by alkali or alkaline earth ions: synthesis and NLO properties
  Huabin Zhang,Shaowu Du CrystEngComm, 2014,16, 4059-4068
• 2. An integrated cathode and solid electrolyte via in situ polymerization with significantly reduced interface resistance?
  Jialiang Yuan,Ran Dong,Yuan Li,Yang Liu,Zhuo Zheng,Yuxia Liu,Yan Sun,Benhe Zhong,Zhenguo Wu,Xiaodong Guo Chem. Commun., 2021,57, 13004-13007
• 3. An integrated process of CO2 capture and in situ hydrogenation to formate using a tunable ethoxyl-functionalized amidine and Rh/bisphosphine system?
  Yu-Nong Li,Liang-Nian He,Xian-Dong Lang,Xiao-Fang Liu,Shuai Zhang RSC Adv., 2014,4, 49995-50002
• 4. An aqueous ammonia sensor based on an inkjet-printed polyaniline nanoparticle-modified electrode
  Karl Crowley,Eimer O'Malley,Aoife Morrin,Malcolm R. Smyth,Anthony J. Killard Analyst, 2008,133, 391-399
• 5. An analysis of the WTC fires using CIB correlations and simple modeling
  JGQuintiere

• Solvents and Organic Chemicals Organic Compounds Benzenoids Thiophenols

Introduction to 3-Bromo-2-methyl-benzenethiol (CAS No: 1263377-44-1)

3-Bromo-2-methyl-benzenethiol, identified by the Chemical Abstracts Service Number (CAS No) 1263377-44-1, is a specialized organic compound that has garnered significant attention in the field of pharmaceutical chemistry and medicinal research. This compound belongs to the class of thiophenols, characterized by the presence of a sulfur atom bonded to a phenyl ring. The structural features of 3-Bromo-2-methyl-benzenethiol, including its bromine and methyl substituents, make it a versatile intermediate in synthetic chemistry, particularly in the development of bioactive molecules.

The bromine atom at the 3-position and the methyl group at the 2-position of the benzene ring contribute to the compound's reactivity, enabling various chemical transformations that are crucial for drug discovery. In recent years, thiophenolic derivatives have been extensively studied due to their broad spectrum of biological activities. These activities include antimicrobial, anti-inflammatory, and anticancer properties, making them valuable candidates for further pharmacological investigation.

Recent advancements in computational chemistry and molecular modeling have enhanced our understanding of how 3-Bromo-2-methyl-benzenethiol interacts with biological targets. Studies have shown that the sulfur atom in thiophenols can form stable interactions with certain amino acid residues in proteins, leading to inhibitory effects on enzyme activity. This has prompted researchers to explore its potential as a scaffold for developing novel therapeutic agents.

One of the most compelling areas of research involving 3-Bromo-2-methyl-benzenethiol is its application in designing small-molecule inhibitors for kinases and other enzymes implicated in cancer progression. Kinases are critical enzymes that regulate numerous cellular processes, and their dysregulation is often associated with tumor growth and metastasis. By targeting these enzymes, 3-Bromo-2-methyl-benzenethiol derivatives have shown promise in preclinical studies as inhibitors of abnormal signaling pathways.

The methyl group at the 2-position not only influences the electronic properties of the benzene ring but also affects the compound's solubility and metabolic stability. These factors are crucial when designing drug candidates, as they determine how well a molecule can be absorbed, distributed, metabolized, and excreted by the body (ADME properties). Optimization of these properties is essential for achieving therapeutic efficacy while minimizing side effects.

In addition to its role as an intermediate in drug synthesis, 3-Bromo-2-methyl-benzenethiol has been explored in materials science. Its ability to participate in cross-coupling reactions makes it useful in synthesizing complex organic molecules that are used in advanced materials, such as conductive polymers and organic semiconductors. These materials have applications in electronics, optoelectronics, and energy storage devices.

The synthesis of 3-Bromo-2-methyl-benzenethiol typically involves bromination and thiolation reactions on a suitable precursor. Advances in synthetic methodologies have enabled more efficient and scalable production processes, which are essential for industrial applications. Techniques such as transition-metal-catalyzed reactions have been particularly useful in achieving high yields and purity levels.

From a medicinal chemistry perspective, derivatives of 3-Bromo-2-methyl-benzenethiol have been investigated for their potential to modulate neurotransmitter systems. Thiophenols are known to interact with receptors and transporters involved in neurological disorders such as depression, anxiety, and Parkinson's disease. By fine-tuning the structure of these derivatives, researchers aim to develop more effective treatments with improved pharmacokinetic profiles.

The growing interest in 3-Bromo-2-methyl-benzenethiol is also driven by its role in developing antiviral agents. The unique structural features of thiophenols allow them to interfere with viral replication mechanisms by inhibiting key enzymes or disrupting viral protein-protein interactions. Several studies have demonstrated the antiviral activity of 3-Bromo-2-methyl-benzenethiol derivatives against various RNA viruses, highlighting their potential as lead compounds for antiviral drug development.

In conclusion,3-Bromo-2-methyl-benzenethiol (CAS No: 1263377-44-1) is a multifaceted compound with significant implications in pharmaceuticals and materials science. Its structural features enable diverse applications ranging from drug development to advanced material synthesis. As research continues to uncover new biological activities and synthetic possibilities,3-Bromo-2-methyl-benzenethiol is poised to remain a valuable compound in scientific endeavors across multiple disciplines.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)